Cyanocobalamin formulations contain trace amounts of cyanide and are contraindicated in patients with Leber's hereditary optic neuropathy
Early haematological response begins with reticulocytosis (increased production of immature red blood cells) typically by day 3-4 of treatment , particularly with injectable forms, though the full resolution of symptoms may take several weeks to months
Copper peptides are generally safe for most people when used topically, as they don't enter the body to produce systemic effects, but copper peptides might not be appropriate for people with a known allergy or sensitivity to copper
any cloudy or discoloured solution should be discarded
This product is NOT intended for human or animal consumption of any kind and are subject to our terms of usage
Low and elevated dose adjustments Low Dose: 1.6 mg total contains 1 mg GHK-Cu and 200 mcg each of BPC-157, TB-4, and KPV